Jade Biosciences (JBIO) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 9, 2026, to be held virtually for stockholders of record as of April 17, 2026.

• Proxy materials, including the proxy statement and annual report, are available online with options for paper or email copies upon request.

Voting matters and shareholder proposals

• Election of two Class Directors, Christopher Cain, Ph.D., and Tom Frohlich, to serve until the 2029 annual meeting.

• Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Approval of an amendment to the Articles of Incorporation to waive jury trials in certain circumstances.

• Provision to transact other business that may properly come before the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends voting for all director nominees and for the listed proposals.